
U.S. Plans to Reclassify Marijuana to Boost Medical Research Opportunities
The U.S. plans to reclassify marijuana to Schedule III, easing research restrictions and potentially leading to new medical products
- •President Trump plans to sign an order reclassifying marijuana to Schedule III
- •Reclassification could ease research restrictions and boost medical product development
- •40 states allow medical marijuana use, but federal approval remains challenging
by U.S. may soon reclassify marijuana to allow medical research. What to know U.S. President Donald Trump is expected to sign an executive order that would reclassify marijuana and ease federal restrictions on research for potential new medical products. U.S. News 6 hours
















